Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by Nacetylcysteine.
Autor: | Orue, Andrea1, Chavez, Valery1, Strasberg-Rieber, Mary1, Rieber, Manuel1 manuel.rieber@gmail.com |
---|---|
Zdroj: | BMC Cancer. 11/18/2016, Vol. 16, p1-16. 16p. 3 Diagrams, 1 Chart, 7 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |